Gujarat Kidney & Super Speciality Limited IPO – Mainboard
About the Company
Gujarat Kidney & Super Speciality Limited, founded in 2008 and headquartered in Vadodara (Central Gujarat), is a regional multi-specialty hospital chain. Think of them as “specialized kidney & urology expert hospitals” with a focus on secondary (surgical) and tertiary (super specialty) care.
Currently, they operate hospitals in Vadodara and Bharuch (Gujarat), with plans to expand aggressively through acquisitions (Parekhs Hospital in Ahmedabad and Ashwini Medical Centre). They specialize in nephrology (kidney disease), urology, dialysis, and super-specialty surgeries. Unlike big chains like Apollo or Max that operate nationwide, they’re focused on the Gujarat-Maharashtra region, where they have deep roots and strong reputation.
READ FULL DRHP HERE: |SEBI DRHP GUJARAT -KIDNEY |
IPO Details Table
| Detail | Explanation | Data |
|---|---|---|
| IPO Opening Date | Buy shares from | 22 Dec 2025 |
| IPO Closing Date | Last date to apply | 24 Dec 2025 |
| Price Band | Price range for shares | ₹108 – ₹114 per share |
| Lot Size | Min. shares to buy | 128 shares (~₹14,592 at upper band) |
| Total Issue Size | Max money raised | ₹250.80 Crore |
| Fresh Issue | New shares, money goes to company | ₹250.80 Crore (2.20 Cr shares = 100%) |
| Offer for Sale (OFS) | Old owners sell shares | Nil (Zero OFS) |
| Listing Date | Shares start trading | 30 Dec 2025 (BSE, NSE) |
| Face Value | Company unit value | ₹2 per share |
| Registrar | Share allocation handler | MUFG Intime India Pvt Ltd |
| Book Managers | IPO arrangers | Citi, Nuvama Wealth Management, HDFC Bank |
REGISTRAR: CLICK HERE
What Will the IPO Money Be Used For?
The company is raising ₹250.80 Crore (Fresh Issue, 100% goes to company) to use for:
- Acquisition of Parekhs Hospital: ₹77 Cr to buy Parekhs Hospital in Ahmedabad (strategic expansion).
- New Hospital in Vadodara: ₹30.10 Cr to build a new super-specialty hospital.
- Ashwini Medical Centre Payment: ₹12.40 Cr (part-payment for already acquired hospital).
- Robotics Equipment: ₹6.83 Cr to buy advanced surgical robots (minimize patient trauma).
- Subsidiary Investment: ₹10.78 Cr to buy more stakes in Harmony Medicare (subsidiary).
- Debt Repayment & Growth: ₹1.20 Cr debt repayment + remaining for acquisitions.
Note: 100% Fresh Issue = All money goes to the company (no OFS). This is very bullish as promoters are investing fresh capital, not exiting.
IPO Timeline
| Event | Date |
|---|---|
| IPO Opens | 22 Dec 2025 |
| IPO Closes | 24 Dec 2025 (5 PM) |
| Allotment Date | 26 Dec 2025 |
| Refunds Issued | 29 Dec 2025 |
| Shares to Demat | 29 Dec 2025 |
| Listing Date | 30 Dec 2025 |
Business Model & Revenue Structure
How They Make Money:
- Inpatient Services (IPD): Hospital admissions for surgeries and treatments (~68% of revenue). Average charge per patient: ₹55,800-67,500.
- Outpatient Services (OPD): Doctor consultations (~13.5% of revenue). ~20,000 OPD patients annually.
- Other Services: Diagnostics, pharmacy, dialysis, lab tests (~18% of revenue).
Patient Mix & Specialties:
- Nephrology & Urology: Core expertise (kidney diseases, urinary issues)
- Dialysis Services: Recurring revenue from chronic kidney disease patients
- General & Super-Specialty Surgery: Orthopedics, gynecology, neurology
- Critical Care (ICU): High-margin intensive care services
Key Financial Metrics:
| Metric | FY23 | FY24 | FY25 | Q1 FY26 (Jul-Sep '25) | Trend |
|---|---|---|---|---|---|
| Revenue | ₹85.79 Cr | ₹103.44 Cr | ₹119.98 Cr | ₹31.09 Cr (annualized ~₹124 Cr) | Growing 16-20% annually |
| EBITDA | ₹17.62 Cr | ₹20.85 Cr | ₹28.91 Cr | ₹13.60 Cr | Operating profit up 64% |
| EBITDA Margin | 20.5% | 20.2% | 24.1% | 43.8% (Q1 annualized) | Expanding margins |
| Net Profit (PAT) | ₹6.35 Cr | ₹9.50 Cr | ₹15.11 Cr | ~₹6 Cr (Q1 normalized) | Profit growing 39% |
| PAT Margin | 7.4% | 9.2% | 12.6% | 19% (Q1 normalized) | Margin expansion excellent |
| ROE | ~12% | ~15% | ~18% | Improving | Strong shareholder returns |
| Debt-to-Equity | 0.73 | 0.60 | 0.22 | 0.18 (est) | Debt declining rapidly |
| ARPOB (Revenue/Bed/Day) | ₹9,305 | ₹9,417 | ₹10,255 | ₹11,243 | Unit economics improving |
Key Points:
- Consistent Growth: Revenue growing 16-20% YoY (strong trajectory).
- Margin Expansion: EBITDA margin improved from 20.5% to 24.1%; PAT margin from 7.4% to 12.6%.
- Debt Reduction: D/E fell from 0.73 to 0.22 (very healthy).
- Unit Economics: ARPOB (revenue per occupied bed-day) growing 7-10% annually, showing pricing power.
- Recent Profitability: Q1 FY26 shows strong profitability with 19% PAT margin (normalized).
Cost of Acquisition – For Promoters
- Promoters: Dr Pragnesh Yashwantsingh Bharpoda (Founder/MD) and family.
- Acquisition Cost: Company built from scratch in 2008 with initial capital ~₹5-10 crore.
- Current Valuation: ₹564 crore market cap at upper IPO price (₹114).
- Promoter Gain: Approximately 50-100x returns over 17 years (2008-2025).
Industry Outlook – India’s Hospital & Dialysis Boom
Growing Opportunity:
- Kidney Disease Crisis: 100+ million Indians have CKD (chronic kidney disease).
- Hospital Bed Shortage: India has only 1.8 beds per 1,000 people (vs 5+ in developed countries).
- Dialysis Boom: Nephrology services growing 20-25% annually.
- Central India Gap: Gujarat/Maharashtra have fewer quality hospitals compared to metros.
Growth Drivers:
- Rising diabetes & hypertension (main CKD causes)
- Aging population
- Growing awareness & insurance coverage
- Government healthcare schemes (Ayushman Bharat)
Growth & Strengths
- Regional Dominance: In Central Gujarat, they’re a household name for kidney care. High brand recall + patient loyalty.
- Recurring Revenue Model: Dialysis patients come 3x per week = 156 visits/year = 10+ years of recurring revenue.
- Unit Economics: ARPOB growing 7-10% annually shows pricing power (patients willing to pay more for quality).
- Debt Decline: D/E fell from 0.73 to 0.22 = Less interest burden → Better profitability.
- M&A Growth Strategy: Smart acquisitions (Parekhs, Ashwini) using IPO proceeds to expand presence.
Key Risks & Concerns
| Risk | Why It Matters | Impact |
|---|---|---|
| Small Regional Player | Only in Vadodara/Bharuch; limited scale vs Apollo/Max | Growth capped by region unless aggressive M&A succeeds |
| Integration Risk | Acquiring 2-3 hospitals in next 2 years | If integrations fail, debt levels rise, margins drop |
| Debt Still Moderate | D/E of 0.22 is good but not pristine | Interest costs drag 1-2% from profitability |
| PSU Payment Risk | If government cuts Ayushman reimbursement rates | Revenue could fall 10-15% |
| Competition Increasing | Apollo, Max, Fortis expanding in Gujarat | Price wars possible; margins could compress |
| Doctor Dependence | Quality depends on senior doctors/specialists | Loss of key doctors could hurt reputation |
| Expensive Valuation | P/E of 40-45x is premium for healthcare | Stock could fall 20-30% post-listing if growth disappoints |
Simple Translation:
- Gujarat Kidney at P/E 40-45x is cheaper than Apollo (99x), Max (79x), Krishna (66x).
- Excellent ROE of 18% is among the best in hospital sector.
- Strong PAT margin of 12.6% shows operational efficiency.
- Low debt (D/E 0.22) is excellent for a capital-intensive hospital business.
- However, valuation assumes 15%+ profit growth for 3-5 years.
IPO FAQS
What is an IPO?
- An IPO (Initial Public Offering) is when a private company sells its shares to the public for the first time to raise money.
- Example: If a well-known pizza company wants to grow, it can list its shares on the stock exchange so anyone can buy a piece of the company.
How can you apply for an IPO (using Zerodha or Upstox)?
- Make sure you have a Demat account and your bank account is linked.
- Steps:
- Log in to your broker’s app (e.g., Zerodha Kite, Upstox).
- Go to the IPO section.
- Select the company’s IPO you want to apply for.
- Enter how many shares (or ‘lots’) you want and the price you wish to bid.
- Enter your UPI ID, submit your application, and approve the UPI payment request.
How are IPO shares allotted?
- If more people want shares than are available, the company uses a lottery system to decide who gets them.
- If you don’t get shares, your money is simply returned.
What is GMP (Grey Market Premium)?
- GMP shows the extra price people are willing to pay for IPO shares before they officially start trading.
- Example: If IPO price is ₹100 and GMP is ₹20, people are unofficially ready to pay ₹120. It hints at the IPO’s popularity but isn’t a guarantee.
Where to check upcoming IPOs (IPO calendar)?
- Visit popular finance sites like Chittorgarh, IPOWatch, or official exchange websites (NSE, BSE) and look for the “Upcoming IPO” section.
What are IPO listing gains?
- If the share’s price rises on the first trading day, you can make instant profit.
- Example: You buy at ₹150, and it opens at ₹200, you gain ₹50 per share.
How can you make profit from an IPO?
- Quick gains on listing day (if the stock price goes up).
- Long-term: If the company grows, the share price could increase further.
Which IPO is best to buy?
- There is no single best IPO. Check the company’s background, current demand, and GMP, but always research before investing.
- High GMP or popularity doesn’t guarantee profits.
Are IPOs safe?
- IPOs can be profitable but also risky; prices can go up or down sharply.
- Only invest if you are ready for potential losses.
How to check IPO allotment status?
- After the IPO process, check on exchanges (BSE/NSE websites) or the IPO registrar’s site (like K-Fintech, Bigshare,or mufg-intime) by entering your PAN or application number to see if you got shares.
Important Tips for Retail Investors Applying for an IPO
- Use Only Your Own PAN Card:
Avoid using the same PAN card for multiple IPO applications. For example, if you have already applied using your PAN for one IPO, don’t try to apply again with the same PAN under different accounts or through others. - Apply in the Right Category:
Ensure you select the correct investor category (such as Retail Individual Investor) when filling out your application. Applying under a wrong category can lead to rejection or disqualification. - Maintain Sufficient Bank Balance:
Before applying, ensure your bank account linked to the application has enough funds to cover the full bid amount. For instance, if the IPO application requires a payment of ₹15000, make sure your account holds at least that amount. - Use Your Own Bank Account:
Always apply through your own bank account. Using someone else’s account can cause your application to be rejected during the verification process. - Avoid Last-Minute Applications:
Don’t wait until the deadline day or moments before to apply. Last-minute submissions may face technical glitches or processing delays, reducing the chances of success.